Looking at options history for Insmed INSM we detected 10 trades. If we consider the specifics of each trade, it is accurate ...

The researchers will continue tracking patients for 5 years, Andréjak said. Meanwhile, the French ministry of health has funded a study to evaluate whether adding amikacin (Arikayce) to the existing ...

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with ...

Q1 2024 net loss of $157.09 million, an improvement from a net loss of $159.76 million in Q1 2023, but still above the ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Insmed (INSM – Research Report). The associated price target ...

In a report released on May 10, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Insmed (INSM – Research Report), with a ...

The biggest advantage lies in the avoidance of injectable medications such as amikacin, which is not only painful but carry terrible side-effects such as hearing loss. “With bedaquiline ...

Antibiotics play a crucial role in combating bacterial infections, but their use, particularly in children, requires careful ...

such as amikacin, tobramycin, or vancomycin Cisplatin, which is a medicine used for treating cancer Does Gentamicin interact with other drugs you are taking? Enter your medication into the WebMD ...